ani-kolleshi-vu-DaZVeny0-unsplash

New report reveals the impact of MedTech collaborations on COVID

A series of reports released today by MTPConnect, an independent, industry-led organisation, highlight the key role the MedTech sector played in the COVID-19 pandemic response. The reports, welcomed by the Medical Technology Association of Australia (MTAA), reveal how the MedTech, biotechnology and pharmaceutical sector was impacted by COVID-19 at local and multinational levels, as well…

COVID-19-image-2_03

VIVA!’s COVID Comms Cast harnessing their health communications expertise “for good”

In response to the rapidly evolving COVID-19 pandemic, and to give back to the Australian health + wellness community, independent health + wellness PR agency, VIVA! Communications (VIVA!), has today (May 4, 2020) launched the ‘COVID Comms Cast’.  Comprising VIVA!’s most senior health + wellness communicators well-versed in navigating issues and crisis-rich environments, this strategic…

Carol Ireland

CEO of Epilepsy Action Australia slams “appalling” TikTok ‘seizure challenge’ trend

CEO of Epilepsy Action Australia, Carol Ireland, released a public statement yesterday, following a recent controversial viral trend on the video app TikTok, known as the “seizure challenge”. Ms Ireland commented she is “appalled that people are pretending to have seizures as if it’s a joke”. The latest challenge to have gone viral on TikTok,…

ZOOM

Top tips for WFH video calls

How to avoid faux pas & respect your fellow zoomies Working from home presents unique challenges and opportunities for those fortunate enough to be able to do so. Businesses and their employees are doing their best to navigate these unprecedented times, so it’s important to practice patience and respect. Here at VIVA! we are doing…

Stethoscope and love heart

Aussies with CVD at higher risk from COVID-19

Tracking the incidence of COVID-19 globally, it is understood that people over the age of 60 with a pre-existing chronic condition, such as cardiovascular disease (CVD) or diabetes, are considered at greater risk to serious infection and complications.1 There has been a high prevalence of CVD in those dying from COVID-19 in Italy and China, two of the worst…

coronavrius

What’s in a name? Coining history’s deadliest pandemics

Here’s some scientific nomenclature to help kick-start your Monday! For centuries before the advent of coronavirus, many contagions, including the Bubonic Plague, syphilis, smallpox and tuberculosis, claimed the lives of hundreds of millions of people worldwide. Ironically, many of these contagions were awarded a ‘rainbow’ of names. Syphilis – a bacterial infection commonly spread by…

The role of strategic communications in helping to navigate unchartered COVID-19 waters

The role of strategic communications in helping to navigate unchartered COVID-19 waters

Our very own VIVA! Communications Principal and owner, Kirsten Bruce, Sydney was recently quoted in pharmaceutical industry publication, Pharma in Focus on how to engage with staff while working from home during the current COVID-19 pandemic. Today, Kirsten shares further insights on how companies should communicate both internally and externally in this challenging, unchartered landscape.…

Telehealth pic

The rise of telehealth

For a long time, access to healthcare has been an ongoing struggle for many rural and remote communities around Australia, with many facing long wait times, limited access to specialist services, and the need to travel long distances to major cities. Furthermore, office-workers and parents with young children often have difficulty finding time to attend…

Multiple Myeloma Awareness: Bone marrow aspirate cytology of multiple myeloma, a type of bone marrow cancer of malignant plasma cells, associated with bone pain, bone  fractures and anemia.

Aussies & Kiwis with incurable blood cancer receive newly subsidised treatment option

Today, VIVA! partnered with Celgene, a Bristol-Myers Squibb company, Multiple Myeloma Australia and Multiple Myeloma New Zealand to announce a newly reimbursed treatment option for Australians and New Zealanders living with incurable blood cancer, multiple myeloma. REVLIMID® (lenalidomide) – the first and only maintenance treatment in ANZ specifically indicated and reimbursed for those with newly…

Media launch with Fed Minister for Health greg Hunt Minister Tanya Davies Minister for Mental Health NSW Dr Michael Spence VC Professor Steve Simpson Prof Janice Russell Prof Stephen Touyz  Tony Carroll Kirsten Bruce Bonny Carroll  Jana Pittman Liam Manning Ash Myburg Christine Morgan

Communicating with personnel during the COVID-19 pandemic

Our own VIVA! Communications Principal and owner, Kirsten Bruce, Sydney was quoted in pharmaceutical industry publication, Pharma in Focus today on how to engage with staff working from home during the current COVID-19 pandemic. She cited the importance of corporate messaging being “clear, concise and reassuring to their employees, customers and stakeholders alike, explaining that…